Results 1 to 10 of about 7,984 (250)

Effects of insulin detemir and NPH insulin on body weight and appetite-regulating brain regions in human type 1 diabetes: a randomized controlled trial. [PDF]

open access: yesPLoS ONE, 2014
Studies in rodents have demonstrated that insulin in the central nervous system induces satiety. In humans, these effects are less well established.
Larissa W van Golen   +7 more
doaj   +17 more sources

Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients [PDF]

open access: goldBMC Endocrine Disorders, 2012
Background The uncertainties regarding dose similarities between basal long-acting insulin analogues remain. Recent real-world studies indicate dose similarities between insulin detemir and insulin glargine, but further studies are still warranted.
Jakobsen Marie   +3 more
doaj   +2 more sources

Sustained Treatment with Insulin Detemir in Mice Alters Brain Activity and Locomotion. [PDF]

open access: yesPLoS ONE, 2016
AIMS:Recent studies have identified unique brain effects of insulin detemir (Levemir®). Due to its pharmacologic properties, insulin detemir may reach higher concentrations in the brain than regular insulin.
Tina Sartorius   +3 more
doaj   +2 more sources

Risk of Major Congenital Malformations or Perinatal or Neonatal Death With Insulin Detemir Versus Other Basal Insulins in Pregnant Women With Preexisting Diabetes: The Real-World EVOLVE Study. [PDF]

open access: bronzeDiabetes Care, 2021
Mathiesen ER   +15 more
europepmc   +5 more sources

Comparative study of the usefulness of a novel insulin therapy in Japanese patients with Type 2 diabetes for concomitant use of an oral antidiabetic agent with twice-daily dosing either of insulin aspart, biphasic insulin aspart-30, or insulin detemir: Two times Insulin injection Combined with oral therapy Efficacy Study (TWICE study) [PDF]

open access: yesFujita Medical Journal, 2021
Objectives: It is common to treat type 2 diabetes by regular injections of insulin. We compared the efficacy and safety of twice-daily administration of short-acting, premixed, and long-acting insulins.
Mitsuyasu Itoh   +9 more
doaj   +2 more sources

The Effect of Insulin Detemir on the Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus

open access: diamondAnkara Üniversitesi Tıp Fakültesi Mecmuası, 2008
Aim: Since there is limited number of studies in medical literature regarding the efficiency of in-sulin detemir, decrease in number of night hypoglycemia, weight changes and the improvement the lipid profile in pediatric and adolescent age group, we ...
Tolga Ünüvar   +4 more
doaj   +3 more sources

Effect of Insulin Detemir (Levemir®) on Risk of Hypoglycaemia and Glycaemic Parameters: Experience from Real Life Practice in Indonesian Patients with Diabetes Mellitus

open access: diamondJournal of the ASEAN Federation of Endocrine Societies, 2011
Objective. To evaluate the safety and efficacy of insulin detemir in patients with diabetes mellitus in Indonesia.   Methods. This was a multi-centre, prospective, 12-week observational study in patients with diabetes mellitus conducted in Indonesia. 
Pradana Soewondo, Anand Jain
doaj   +2 more sources

Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain [PDF]

open access: gold, 2015
Introduction: An Excel® (Microsoft Corporation) model was adapted to estimate the short-term (1-year) cost effectiveness of insulin detemir (IDet) versus neutral protamine Hagedorn (NPH) insulin in patients initiating insulin treatment with type 1 ...
Cristóbal Morales   +4 more
openalex   +5 more sources

The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus [PDF]

open access: yesDiabetology & Metabolic Syndrome, 2017
Background Type II diabetes is an important health problem with a complex connection to obesity, leading to a broad range of cardiovascular complications.
Tomislav Bozek   +8 more
doaj   +2 more sources

Adiponectin, Leptin, and Leptin Receptor in Obese Patients with Type 2 Diabetes Treated with Insulin Detemir [PDF]

open access: yesMolecules, 2017
The aim of the present study is to quantitatively assess the expression of selected regulatory molecules, such as leptin, leptin receptor, and adiponectin in the blood of obese patients with type 2 diabetes both before treatment and after six months of ...
Paweł Olczyk   +9 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy